Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
48,384,504
-
Share change
-
-4,196,467
-
Total reported value
-
$712,391,078
-
Put/Call ratio
-
223%
-
Price per share
-
$14.76
-
Number of holders
-
152
-
Value change
-
-$58,543,811
-
Number of buys
-
78
-
Number of sells
-
73
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q2 2020
As of 30 Jun 2020,
AERIE PHARMACEUTICALS INC - COM (AERI) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,384,504 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Partner Fund Management, L.P., BANK OF AMERICA CORP /DE/, LEVIN CAPITAL STRATEGIES, L.P., FRED ALGER MANAGEMENT, LLC, CITADEL ADVISORS LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Bank of New York Mellon Corp, and RICE HALL JAMES & ASSOCIATES, LLC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.